DanielCharlesBowersMD

Pediatric Hematology & Oncology • Dallas, TX

Pediatric Hematologic Oncology

Professor of Pediatrics, Division of Pediatric Henatology-Oncology, University of Texas Southwestern Medical Center, Dallas, Texas

Join to view full profile

Dr. Bowers is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bowers' full profile

Already have an account?

Office
5323 Harry Hines Boulevard
Dallas, TX 75390
Phone+1 214-456-2382

Summary

Dr. Daniel Bowers, pediatric neuro-oncologist in Dallas - UT Southwestern

Pediatric neuro-oncologist Daniel Bowers, M.D., cares for children with brain tumors, along with other members of the pediatric brain tumor multidisciplinary te

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1996 - 1999
University of Texas Southwestern Medical CenterResidency, Pediatrics, 1993 - 1996
University of Texas Southwestern Medical SchoolClass of 1993
Texas A&M UniversityB.S., Biology, Magna Cum Laude, 1985 - 1989

Certifications & Licensure

TX State Medical License 1994 - 2026
MD State Medical License 1996 - 2000
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Favorite Oncology Professionals CureSearch for Children’s Cancer http://www.curesearch.org/Favorite-Oncology-Professionals-Announced/, 2013
Recognized by: Gralow J, Ozols RF, Bajorin DF, et al. Clinical Cancer Advances 2007: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology. Journal of Clinical Oncology, 2008
Elected to the Society for Pediatric Research 2006
Selected for Marquis Who’s Who in America® 2006
Selected to the “Best Pediatricians in Dallas” D Magazine, 2003-2004, 2007, 2011, 2013
Outstanding Graduate in the College of Science Texas A&M University, College Station, TX, 1989
Join now to see all

Clinical Trials

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma Start of enrollment: 2007 Dec 17
Active, not recruiting
Phase 2
A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors Start of enrollment: 2005 Jan 01
Completed
Phase 2
Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma Start of enrollment: 2009 Sep 01
Completed
Phase 2
Childhood Cancer Survivor Study Start of enrollment: 1995 Jan 05
Recruiting
Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) Start of enrollment: 2011 Sep 01
Terminated
Phase 2
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma Start of enrollment: 2013 Jun 23
Active, not recruiting
Phase 2
Everolimus for Children With Recurrent or Progressive Ependymoma Start of enrollment: 2015 Feb 01
Completed
Phase 2
Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma Start of enrollment: 2017 Apr 04
Terminated
Early Phase 1
Strict Classic Ketogenic Diet as a Therapy for Recurrent or Progressive and Refractory Brain Tumors in Children Start of enrollment: 2024 Jul 01
Withdrawn
Not Applicable
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT Start of enrollment: 2021 Jul 13
Recruiting
Phase 2
Roles: Principal Investigator, Contact
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) Start of enrollment: 2023 Jan 23
Recruiting
Phase 3
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

532 citations
Comprehensive Analysis of Hypermutation in Human Cancer
Brittany Campbell, Nicholas Light, David Fabrizio, Matthew Zatzman, Fabio Fuligni
Cell. 2017-11-16
67 citations
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Jason Fangusaro, Olaf Witt, Pablo Hernáiz Driever, Asim K Bag, Peter de Blank
The Lancet. Oncology. 2020-06-01
56 citations
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Craig Erker, Benita Tamrazi, Tina Y Poussaint, Sabine Mueller, Daddy Mata-Mbemba
The Lancet. Oncology. 2020-06-01

Journal Articles

Imaging of Pediatric Cerebellar Tumors
Koral K, Koral KM, Bowers DC, Timmerman RD, Journal of Pediatric Neuroradiology, 1/1/2012
In Reply – Stroke as a late treatment effect of Hodgkin's disease
Bowers DC, Oeffinger KC, Journal of Clinical Oncology, 1/1/2006
Cerebrovascular Dysfunction in Children with Neoplastic Disorders
Bowers DC, Symposiums on Stroke and Cerebrovascular Disease, 1/1/2001